Please login to the form below
HIV
This page shows the latest HIV news and features for those working in and with pharma, biotech and healthcare.
CHMP backs Bayer’s tumour-agnostic drug Vitrakvi
periods in Parkinson’s disease, as well as Theratechnologies’ Trogarzo (ibalizumab) as an add-on treatment for drug resistant HIV.
Latest news
-
HIV meeting hears progress towards vaccine and cure
Hope for global treatment. While combination treatment regimens have transformed the prospects for people with HIV, an effective preventive vaccine or cure remains elusive. ... In 2017, 1.8m people were newly infected with HIV and nearly 1 million people
-
Gilead strikes $5.1bn deal to bolster ties with Galapagos
suffering from a dramatic decline in hepatitis C sales, increased pressure in its HIV franchise, and with a lot of work still to be done on its push to diversify into
-
ViiV builds case for switching to its two-drug HIV combinations
Taking aim at rival Biktarvy. ViiV Healthcare says it has data that shows people with HIV can safely switch from Gilead's three-drug therapies to one of its two-drug ... ViiV – which is majority owned by GlaxoSmithKline – has a lot riding on being
-
ViiV bags EU okay for new two-drug HIV therapy
Rivals Gilead's Biktarvy. ViiV Healthcare now has approval on both sides of the Atlantic for two-drug HIV therapy Dovato after a green light from the EMA. ... Dovato was approved in the US in April as a single-tablet, once-daily regimen for
-
Merck says it has plenty in the pipe beyond Keytruda
fever, plus a new HIV drug – MK-8591 – that Merck thinks could be a major step forward in pre-exposure prophylaxis (PrEP).
More from news
Approximately 85 fully matching, plus 503 partially matching documents found.
Latest Intelligence
-
Biotech profile: Tom Evans, CEO, Vaccitech.
He established a laboratory during his first position at the University of Utah and directed the HIV clinic. ... His academic research centered on leishmania and HIV vaccine development and led to him joining Vical, a DNA vaccine developer as Chief
-
Crossing the digital divide between big pharma and real-world patients
ViiV Healthcare is a prime example of a company taking this seriously – it uses Twitter to engage with and support the HIV community, and to tackle the stigma around HIV through
-
Combining therapies and combining research
Combination therapy is the norm in the treatment of many cancers and viral infections such as HIV and even some bacterial diseases such as tuberculosis.
-
2019: CRISPR and therapeutic gene editing comes of age
HIV infection – has injected a massive dose of controversy to the field even as it takes its first steps into human clinical testing.
-
Redefining communications excellence
In 2016, Gilead broke its self-enforced moratorium on the marketing of Truvada for PrEP, its drug for preventing HIV. ... A separate survey found 57% of resident trainees did not know the local rate of HIV.
More from intelligence
Approximately 3 fully matching, plus 46 partially matching documents found.
Latest appointments
-
Aelix Therapeutics appoints Dr Thomas Hecht
its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the
-
emotive boosts its client services team
Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.
-
GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet
GlaxoSmithKline has promoted Deborah Waterhouse to replace ViiV Healthcare's CEO Dominique Limet when he steps down from the HIV-focused firm at the end of March. ... We have delivered scientific innovation, while listening and better understanding the
-
Bionor names executive management team additions
Three new starters including chief operating officer and interim CFO. HIV and deadly virus firm Bionor Pharma has revealed a number of new additions to its executive management team. ... Together, they bring a wealth of experience to advance therapeutic
-
MHP Health strengthens team with four hires
She also volunteers for two HIV charities: one based in London, which supports young people who have family members affected by HIV and one that supports the work of people in
More from appointments
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
Tactful screening & participant sensitivity
If HIV positive > screen out. Current weight and amount of weight lost (in a given time period).
-
Havas Lynx Group lifts a silver Cannes Lion with landmark HIV campaign
Communicating a landmark moment for the HIV community has helped a leading healthcare communications agency secure another award at the famous Cannes Lions International Festival of Creativity. ... U=U= is such an emotional film and is extremely
-
90TEN named Best Agency in Continental Europe at PRWeek Global Awards
Refreshing self-awareness”. 90TEN’s Flight HIV101 campaign, on behalf of Gilead, aimed to help gay men living with HIV discuss long-term health with their doctor. ... It centred around a flight safety comedy short featuring HIV-positive drag queen
-
'Fake news': battling misinformation in healthcare
For example, even subtly suggesting there will soon be a cure for HIV inflates expectations of current research. ... HIV currently affects 30 million people, misinformation promotes false-hope and leaves patients feeling soul-crushingly let-down, dashing
-
“HIV Has Changed” Havas Life Manchester unveils powerful pop-up plant installation to launch national awareness campaign
It reads:. #HIVHasChanged. Today, HIV is a treatable long-term condition. People living with HIV can lead full and healthy lives. ... The HIV installation is intentionally bold and eye catching, designed to catch public and media attention….hopefully a
More from PMHub
Approximately 4 fully matching, plus 42 partially matching documents found.
Featured jobs
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- The relevance of patient perspectives to value
- Sanofi patent case win holds off generic rivals for key cancer drug
- Leo Pharma to market AstraZeneca’s brodalumab outside Europe
- Regeneron scores positive data in phase 3 cholesterol trial
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Putting our core values into practice at the Porterhouse summer social
PMHub
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
